fashion -WSS

fashion

author：fashion 2025-09-06 03:17:35 - browse：82

Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： The biotech scorecard for Q1: 17 stock

entertainment

WSS

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Chronically ill young patients struggle to find fertility info

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

The biotech scorecard for Q1: 17 stock

J&J to buy cancer drug developer Ambrx Biopharma

GSK Flovent asthma inhalers replaced by authorized generics

leisure time

fashion

knowledge

Guidelines to prevent youth baseball injuries need more muscle

Burning questions for the 2024 JPM Healthcare Conference

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Virginia high school admissions case could be legal follow

FDA's naming rule on biosimilars has undermined competition

BioMarin wins approval for gene therapy to treat hemophilia A

States should stop sabotaging methadone treatment reform

focus

There's no autism epidemic. It's an autism diagnosis epidemic

Feng Zhang CRISPR delivery startup lays off quarter of staff

Federal weight loss drug coverage is 30 years out of date

3 trends to watch in health tech's hiring outlook for 2024

Decaf coffee targeted by food safety group under obscure FDA rule

States should stop sabotaging methadone treatment reform

entertainment

explore

Wikipedia

focus